FA
SRNE

Fiduciary Alliance’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Fiduciary Alliance’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,250
Closed -$1.11K – 934
2022
Q4 		$1.11K Buy
+1,250
New +$1.11K ﹤0.01% 767